跳至主要内容
临床试验/EUCTR2014-001314-25-NL
EUCTR2014-001314-25-NL进行中(未招募)不适用

The effect of on demand versus continuous use of proton pump inhibitors on reflux symptoms, quality of life and self-rated health in patients with gastro-oesophageal reflux disease

Karolinska Institutet0 个研究点目标入组 700 人开始时间: 2014年7月21日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • * Age 18-65 years
  • * Predominant GORD cases with heartburn and/or acid regurgitation that need PPI treatment
  • * PPI responsive
  • * Ability to complete questionnaires
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 700
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • * Known Barrett’s oesophagus
  • * Known severe oesophagitis (LA C or above)
  • * Continuous use of NSAID/aspirin
  • * Prophylactic PPI use to reduce the risk of ulcers in persons being treated with NSAIDs
  • * PPI treatment to heal an ulcer induced by NSAID treatment in the last 6 months
  • * PPI treatment for H. pylori eradication in the last 6 months
  • * Severe disorders other than GORD with a negative impact on quality of life
  • * Signs of upper gastrointestinal bleeding
  • * Alarm symptoms: unintentional weight loss/vomiting/difficulties swallowing
  • * Pregnancy

研究者

相似试验